Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
MarketBeat on MSN10h
4 Reasons Pfizer Could Be a Value Play You Can't MissPfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) ...
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
MT Newswires on MSN3d
European Equities Traded in the US as American Depositary Receipts Higher in Friday TradingEuropean equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.23% to 1,417.34 on the S&P Europe Select ADR Index. For the week, the index is down about 1 ...
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback